EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

A real-world retrospective cohort study reveals the clinical utility of metagenomic next-generation sequencing in lower respiratory tract infections

Qianfang Hu, Tao Wan, Yan Liu, Houyu Zhong, Yuhan Chen, Zhi Ao, Xingxing Jin, Shuliang Guo

Journal of Infection and Public Health · 2026

DOI: 10.1016/j.jiph.2026.103332 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Infection and Public Health, 2026. Verfasst von Qianfang Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China; Respiratory Ch…. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Respiratory Tract Infections, Metagenomics. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Project of Technological Innovation Application Development Plan of Chongqing City.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Lower respiratory tract infections (LRTIs) are complicated by diverse pathogens, posing challenges to traditional diagnostics. However, robust evidence on LRTI pathogen spectra and metagenomic next-generation sequencing (mNGS) clinical utility remains limited. METHODS: A retrospective analysis was conducted among 815 patients with suspected LRTIs who underwent mNGS and conventional microbiological testing(CMT) of bronchoalveolar lavage fluid. We evaluated the pathogen spectrum, the diagnostic value of mNGS across different infection categories, and its utility in guiding antibiotic therapy. RESULT: Following exclusions, 754 patients demonstrated 84.5% mNGS positivity. mNGS detected DNA viruses (33.85%, EBV predominating), bacteria (30.83%), fungi (23.30%), mycobacteria (9.43%), and special pathogens (2.59%). Confirmed pathogens included Mycobacterium tuberculosis (n = 124), Candida albicans (n = 118), Pseudomonas aeruginosa (n = 87), Pneumocystis jirovecii (n = 65), Haemophilus influenzae (n = 50) and Aspergillus fumigatus (n = 48). mNGS showed higher positivity than CMT (84.5% vs 53.6%, P < 0.05), with sensitivities of 90.6% (LRTIs), 73.3% (bacterial), 74.7% (fungal), and 81.9% (tuberculosis); specificities were 22.6%, 56.5%, 73.5%, and 96.4%. Its high sensitivity but modest specificity necessitates cautious interpretation. mNGS guided treatment adjustments in 48.4% of patients, with higher rates in critically ill patients (60.1% vs 45.7%, P < 0.05), though clinical improvement was lower in this group (54.7% vs 79.2%, P < 0.05). CONCLUSIONS: mNGS comprehensively detects pathogens in LRTIs, including bacteria, fungi, mycobacteria, DNA viruses, and special pathogens. While its broad diagnostic value and treatment guidance utility are significant, integration with clinical context is essential to distinguish true pathogens from colonization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

High-Throughput Nucleotide SequencingRespiratory Tract InfectionsMetagenomicsHumansRetrospective StudiesFemaleBronchoalveolar Lavage FluidMaleMiddle AgedBacteriaAgedSensitivity and SpecificityAdultVirusesFungiAged, 80 and over

Stichwörter der Autor:innen

Bronchoalveolar lavage fluidClinical utilityLower respiratory tract infectionsMetagenomic next-generation sequencing

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China; Respiratory Chronic Diseases and Comorbidities,Key Laboratory of Chongqing Education…
  • Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Electronic address: 591230201@qq.com.

Förderung

  • Key Project of Technological Innovation Application Development Plan of Chongqing City

Zitieren

APA

Hu, Q., Wan, T., Liu, Y., Zhong, H., Chen, Y., Ao, Z., Jin, X., & Guo, S. (2026). A real-world retrospective cohort study reveals the clinical utility of metagenomic next-generation sequencing in lower respiratory tract infections. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2026.103332

Vancouver

Hu Q, Wan T, Liu Y, Zhong H, Chen Y, Ao Z, et al. A real-world retrospective cohort study reveals the clinical utility of metagenomic next-generation sequencing in lower respiratory tract infections. Journal of Infection and Public Health. 2026. doi:10.1016/j.jiph.2026.103332

BibTeX
@article{Hu2026,
  author = {Hu, Qianfang and Wan, Tao and Liu, Yan and Zhong, Houyu and Chen, Yuhan and Ao, Zhi and Jin, Xingxing and Guo, Shuliang},
  title = {A real-world retrospective cohort study reveals the clinical utility of metagenomic next-generation sequencing in lower respiratory tract infections},
  journal = {Journal of Infection and Public Health},
  year = {2026},
  doi = {10.1016/j.jiph.2026.103332}
}
Kostenlos starten →